Article Details
Retrieved on: 2022-06-05 12:17:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
By Natalie Grover. LONDON (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu extended survival by more than six months in patients with a form ...
Article found on: gazette.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here